Cancer Prevention Pharmaceuticals

Cancer Prevention Pharmaceuticals develops prevention therapies for people with elevated risk for cancer in the U.S.

Cancer Prevention Pharmaceuticals, Inc. engages in the development and production of pharmaceutical agents to prevent cancers in people with elevated risk for these diseases in the United States. The company offers difluoromethylornithine for clinical cancer prevention and treatment trials. It also develops diagnostic methods to identify individuals who are at high risk for specific cancers and medicine-related toxicities. In addition, the company develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers. Cancer Prevention Pharmaceuticals, Inc. was incorporated in 2008 and is based in Tucson, Arizona.